A
AGILENT TECHNOLOGIES, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$156.47
+0.08%Next report
Analyst consensus
- Next report date
- Nov 23, 2026
- EPS estimate
- $1.72
- Revenue estimate
- $2.0B
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- $1.62
- EPS estimate
- $1.49
- Revenue actual
- $1.9B
- Revenue estimate
- $1.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +3.5%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $180
- PT range
- $172 – $190
- Analysts
- 12
12 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 26, 2026 | $1.49 | $1.62 | Beat 8.72% | $1.9B |
| May 27, 2026 | $1.41 | $1.49 | Beat 5.67% | $1.8B |
| Feb 25, 2026 | $1.37 | $1.36 | Miss -0.73% | $1.8B |
| Nov 24, 2025 | $1.58 | $1.59 | Beat 0.44% | $1.8B |
| Aug 27, 2025 | $1.37 | $1.37 | Beat 0.07% | $1.7B |
| May 28, 2025 | $1.26 | $1.31 | Beat 4.05% | $1.7B |
| Feb 26, 2025 | $1.28 | $1.31 | Beat 2.42% | $1.7B |
| Nov 25, 2024 | $1.41 | $1.46 | Beat 3.77% | $1.7B |
| Aug 21, 2024 | $1.26 | $1.32 | Beat 4.60% | $1.6B |
| May 29, 2024 | $1.19 | $1.22 | Beat 2.35% | $1.6B |
| Feb 27, 2024 | $1.22 | $1.29 | Beat 5.39% | $1.7B |
| Nov 20, 2023 | $1.35 | $1.38 | Beat 2.37% | $1.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 23, 2026